Sorrento Investors Rip Atty Fee Requests Over 'Scant' Results

By Yun Park · July 11, 2024, 7:15 PM EDT

A group of Sorrento Therapeutics Inc. shareholders has asked a Texas bankruptcy judge to reject $50 million in fee applications by lawyers for the drug developer, charging that the Chapter 11...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

California biopharmaceutical firm Sorrento Therapeutics Inc., filed for Chapter 11 protection with about $135 million in debt, in the face of a $175 million arbitration award.

Case Number

4:23-bk-90085

Judge

Christopher M. Lopez

Venue

U.S. Bankruptcy Court for the Southern District of Texas

Capital Structure

View Full Scorecard

Documents

Related Sections

Case Information

Case Title

Sorrento Therapeutics, Inc.

Case Number

4:23-bk-90085

Court

Texas Southern

Nature of Suit

Date Filed

February 13, 2023

Recent Articles By Yun